Literature DB >> 15563561

Effect of sodium balance and the combination of ultrafiltration profile during sodium profiling hemodialysis on the maintenance of the quality of dialysis and sodium and fluid balances.

Joon Ho Song1, Geun Ho Park, Sun Young Lee, Seung Won Lee, Seoung Woo Lee, Moon-Jae Kim.   

Abstract

Excessive sodium gain is a major hindrance of sodium profiling hemodialysis (HD) that offsets the benefit in reducing intradialytic hypotension-related discomforts (IHD). Patients who showed frequent IHD (>30% of the sessions; n = 11) were enrolled in a prospective study that consisted of two phases. In the phase 1 study, eight treatment modalities were evaluated: Conventional HD (control), sodium balance-positive step-down sodium profiling HD (PS), sodium balance-neutral step-down sodium profiling HD (NS), sodium balance-neutral alternating sodium profiling HD (NA) without ultrafiltration (UF) profile, and all those with UF profile (UF only, PS+U, NS+U, and NA+U). The incidences of "dialysis failure," defined as the occurrence of one or more of (1) session failure (discontinuation of session <75% of planned time), (2) UF failure (%UF achieved <70%), and (3) delivery failure (Kt/V <1.1), were 48.5, 21.2, 42.4, 39.4, 45.5, 18.2, 21.2, and 18.2% in control, PS, NS, NA, UF only, PS+U, NS+U, and NA+U, respectively. Four treatments, PS, PS+U, NS+U, and NA+U, reduced the incidence of dialysis failure significantly as compared with control (P < 0.05) and were evaluated in the phase 2 study, a randomized controlled 6-wk crossover study. Parameters were measured in the steady state after a 6-wk maintenance of each treatment. Diffusive sodium gain (DeltaNa) was significantly increased with sodium balance-positive profiles with or without UF profile, PS and PS+U (PS 1.9 +/- 1.1, PS+U 1.7 +/- 1.0 mEq/L; both P < 0.05 to control -0.1 +/- 0.2, NS+U 0.5 +/- 0.4, NA+U 0.4 +/- 0.2 mEq/L). They also increased the interdialytic weight gain (PS 3.8 +/- 0.6, PS+U 4.0 +/- 0.6 kg; both P < 0.05 to control 2.7 +/- 0.6, NS+U 3.3 +/- 0.6 kg; both P = NS to NA+U 3.5 +/- 0.6 kg). Predialysis weight and the required amount of UF also increased significantly with these sodium balance-positive profiles. Although the absolute amount of UF was larger with PS and PS+U, %UF achieved targeting dry weight was higher with sodium balance-neutral profiles with UF profiles, NS+U and NA+U (NS+U 92.7 +/- 3.8, NA+U 93.7 +/- 6.8%; both P < 0.05 to control 72.6 +/- 14.0, PS 88.3 +/- 6.6, PS+U 88.2 +/- 8.2%). Postdialysis weight was closest to dry weight with these treatments showing Delta (postdialysis weight - dry weight) of 0.3 +/- 0.1 and 0.3 +/- 0.2 kg in NS+U and NA+U (both P < 0.05 to control 1.0 +/- 0.6 kg; both P = NS to PS 0.5 +/- 0.3, PS+U 0.5 +/- 0.4 kg). Incidence of excessive weight gain and subjective discomforts during the interdialytic period increased significantly with PS. In conclusion, continuous use of sodium balance-positive sodium profiles resulted in an undesirable steady state with sodium and fluid expansion offsetting their hemodynamic benefit. Sodium balance-neutral sodium profiles in combination with UF profile were associated with less sodium and weight gains, better UF performance with postdialysis weight closest to dry weight, and fewer interdialytic problems with the equivalent hemodynamic benefit. Therefore, it is proposed that sodium balance-neutral sodium profiling HD with UF profile is a better choice, ensuring the dialysis of quality without sodium gain-related complications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15563561     DOI: 10.1681/ASN.2004070581

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  34 in total

1.  Sodium removal and plasma tonicity balance are not different in hemodialysis and hemodiafiltration using high-flux membranes.

Authors:  Vincenzo La Milia; Chiara Ravasi; Fabio Carfagna; Elena Alberghini; Ivano Baragetti; Laura Buzzi; Francesca Ferrario; Silvia Furiani; Gaia Santagostino Barbone; Giuseppe Pontoriero
Journal:  J Nephrol       Date:  2019-01-10       Impact factor: 3.902

Review 2.  Hypertension in Pediatric Dialysis Patients: Etiology, Evaluation, and Management.

Authors:  Raj Munshi; Joseph T Flynn
Journal:  Curr Hypertens Rep       Date:  2018-06-08       Impact factor: 5.369

3.  Dialysate sodium, serum sodium and mortality in maintenance hemodialysis.

Authors:  Finnian R Mc Causland; Steven M Brunelli; Sushrut S Waikar
Journal:  Nephrol Dial Transplant       Date:  2011-09-02       Impact factor: 5.992

4.  Association of Predialysis Calculated Plasma Osmolarity With Intradialytic Blood Pressure Decline.

Authors:  Finnian R Mc Causland; Sushrut S Waikar
Journal:  Am J Kidney Dis       Date:  2015-05-12       Impact factor: 8.860

5.  Continuous monitoring of blood pressure by analyzing the blood flow sound of arteriovenous fistula in hemodialysis patients.

Authors:  Yuka Kamijo; Eiichiro Kanda; Hayato Horiuchi; Noriyuki Kounoue; Keisuke Ono; Keizo Maeda; Akane Yanai; Kazuya Honda; Ryuji Tsujimoto; Mai Yanagi; Yoshitaka Ishibashi; Masayuki Yoshida
Journal:  Clin Exp Nephrol       Date:  2017-11-10       Impact factor: 2.801

6.  Definitions of intradialytic hypotension.

Authors:  Magdalene M Assimon; Jennifer E Flythe
Journal:  Semin Dial       Date:  2017-07-09       Impact factor: 3.455

Review 7.  Epidemiology, diagnosis and management of hypertension among patients on chronic dialysis.

Authors:  Panagiotis I Georgianos; Rajiv Agarwal
Journal:  Nat Rev Nephrol       Date:  2016-08-30       Impact factor: 28.314

8.  The value of sequential dialysis, mannitol and midodrine in managing children prone to dialysis failure.

Authors:  Daljit K Hothi; Elizabeth Harvey; Cristina M Goia; Denis Geary
Journal:  Pediatr Nephrol       Date:  2009-03-18       Impact factor: 3.714

9.  Preservation of blood pressure stability with hypertonic mannitol during hemodialysis initiation.

Authors:  Finnian R Mc Causland; Lisa M Prior; Eliot Heher; Sushrut S Waikar
Journal:  Am J Nephrol       Date:  2012-07-26       Impact factor: 3.754

10.  Dialysis dose and intradialytic hypotension: results from the HEMO study.

Authors:  Finnian R Mc Causland; Steven M Brunelli; Sushrut S Waikar
Journal:  Am J Nephrol       Date:  2013-10-26       Impact factor: 3.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.